Your browser doesn't support javascript.
loading
Low-dose ponatinib is a good option in chronic myeloid leukemia patients intolerant to previous TKIs.
Iurlo, Alessandra; Cattaneo, Daniele; Malato, Alessandra; Accurso, Vincenzo; Annunziata, Mario; Gozzini, Antonella; Scortechini, Anna Rita; Bucelli, Cristina; Scalzulli, Emilia; Attolico, Imma; Maggi, Alessandro; Martino, Bruno; Caocci, Giovanni; Abruzzese, Elisabetta; Pregno, Patrizia; Luciano, Luigiana; Breccia, Massimo.
Afiliação
  • Iurlo A; Division of Hematology, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Cattaneo D; Division of Hematology, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Malato A; Division of Hematology, Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy.
  • Accurso V; Division of Hematology, AOU Policlinico "P. Giaccone", University of Palermo, Palermo, Italy.
  • Annunziata M; Division of Hematology, AORN Cardarelli, Naples, Italy.
  • Gozzini A; Division of Hematology, AOU Careggi, Florence, Italy.
  • Scortechini AR; Division of Hematology, Department of Molecular and Clinical Sciences, Polytechnic University of Marche, Ancona, Italy.
  • Bucelli C; Division of Hematology, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Scalzulli E; Division of Hematology, Department of Precision and Translational Medicine, Policlinico Umberto 1, Sapienza University, Rome, Italy.
  • Attolico I; Division of Hematology and Transplant Unit, Policlinico of Bari, Bari, Italy.
  • Maggi A; Division of Hematology, Hospital "S.G. Moscati", Taranto, Italy.
  • Martino B; Division of Hematology, Azienda Ospedaliera "Bianchi Melacrino Morelli", Reggio Calabria, Italy.
  • Caocci G; Hematology Unit, Department of Medical Sciences and Public Health, Businco Hospital, University of Cagliari, Cagliari, Italy.
  • Abruzzese E; Division of Hematology, Sant'Eugenio Hospital, Rome, Italy.
  • Pregno P; Division of Hematology, AOU Città della Salute e della Scienza, Turin, Italy.
  • Luciano L; Division of Hematology, Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy.
  • Breccia M; Division of Hematology, Department of Precision and Translational Medicine, Policlinico Umberto 1, Sapienza University, Rome, Italy.
Am J Hematol ; 95(10): E260-E263, 2020 10.
Article em En | MEDLINE | ID: mdl-32557788
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piridazinas / Leucemia Mielogênica Crônica BCR-ABL Positiva / Inibidores de Proteínas Quinases / Imidazóis Tipo de estudo: Observational_studies / Prognostic_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Am J Hematol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Itália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piridazinas / Leucemia Mielogênica Crônica BCR-ABL Positiva / Inibidores de Proteínas Quinases / Imidazóis Tipo de estudo: Observational_studies / Prognostic_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Am J Hematol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Itália